Subcutaneous administration takes less time and is tied to fewer administration-related reactions than intravenous.
Many professionals report awareness, but few actively prescribe the self-administered injectable contraceptive DMPA.
With star checkpoint inhibitors like Keytruda and Opdivo now sporting subcutaneous formulations, GSK has struck a deal aimed ...
The U.S. Food and Drug Administration has approved the Zycubo (copper histidinate) injection as the first treatment for ...
Alteogen and Tesaro, a subsidiary of GSK, have entered an exclusive license agreement concerning a subcutaneous formulation of dostarlimab.
The Food and Drug Administration (FDA) has approved Zycubo® (copper histidinate) for the treatment of Menkes disease in pediatric patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback